In conjunction with mast cell alterations, we observed that there was CML-induced intestinal remodeling as evidenced by a marked increase in small intestinal, but not colonic, length that was partially attenuated by IL-9 signaling blockade (Fig. 4g). The gene discussed is IL9; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.